Current Vertex Pharmaceuticals forecasts and price targets in August 2026
Ø Analyst Price Targets
532.50 USD
+1.29 %
Median
540.60 USD
+2.83 %
Max
656.25 USD
Min
360.99 USD
Last Price
525.73 USD
Buy
30
Hold
8
Sell
1
The average target price for Vertex Pharmaceuticals is 532.50 USD. (+1.29 % above the current price)
The median price target of Vertex Pharmaceuticals is 540.60 USD.
Stock analysts from many renowned investment banks are closely examining the Vertex Pharmaceuticals stock. They conclude their professional Vertex Pharmaceuticals stock analyses with a clear recommendation for the Vertex Pharmaceuticals stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 30 | 8 | 1 | 532.50 USD |
| 2026-01-01 | 26 | 12 | 1 | 507.58 USD |
| 2025-12-01 | 25 | 13 | 1 | 501.03 USD |
| 2025-12-01 | 25 | 13 | 1 | 496.99 USD |
| 2025-11-01 | 25 | 13 | 1 | 495.66 USD |
| 2025-11-01 | 25 | 13 | 1 | 491.86 USD |
Vertex Pharmaceuticals Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Vertex Pharmaceuticals in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 13.19 B USD | 4.83 B USD | 18.87 USD |
| 2027e | 14.58 B USD | 5.53 B USD | 21.60 USD |
| 2028e | 16.02 B USD | 6.42 B USD | 25.06 USD |